Formocortal (INN), also known as fluoroformylone, is a corticosteroid used in dermatology[1] and ophthalmology.[2]
Clinical data | |
---|---|
Other names | 3-(2-chloroethoxy)-6-formyl-9α-fluoropregna-3,5-diene-11β,16α,17,21-tetrol-20-one 21-acetate |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
Chemical and physical data | |
Formula | C29H38ClFO8 |
Molar mass | 569.06 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
It was introduced in around 1970[1] and is not known to be marketed as of 2021[update].
See also
editReferences
edit- ^ a b Aliperta G, Lattaro R (November 1971). "[On the topical use of a new steroid, formocortal, in the treatment of phlebodermitis and in cutaneous auto- and homo-grafts]". Minerva Cardioangiologica. 19 (11): 620–624. PMID 4942789.
- ^ Marchese A, Bozzolasco M, Gualco L, Schito GC, Debbia EA (2001). "Evaluation of spontaneous contamination of ocular medications". Chemotherapy. 47 (4): 304–308. doi:10.1159/000048538. PMID 11399868. S2CID 33870589.